InfliximabVarious toxicities: 5 case reports

被引:0
作者
机构
关键词
D O I
10.1007/s40278-018-50410-3
中图分类号
学科分类号
摘要
引用
收藏
页码:230 / 230
相关论文
共 1 条
  • [1] Ratnakumaran R(2018)Efficacy and tolerability of initiating, or switching to, infliximab biosimilar CT-P13 in inflammatory bowel disease (IBD): a large single-centre experience. Scandinavian Journal of Gastroenterology 53 700-707